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In the literature, there have been several attempts to develop 
prediction models for youth who are at clinical high risk 
(CHR) of developing psychosis. Although there are no spe-
cific clinical or demographic variables that seem to consis-
tently predict the later transition to psychosis in those CHR 
youth, in addition to attenuated psychotic symptoms, the 
most commonly occuring predictors tend to be poor social 
functioning and certain cognitive tasks. Unfortunately, 
there has been little attempt to replicate alogorithms. 
A recently published article by Cornblatt et al suggested 
that, for individuals with attentuated psychotic symptoms 
(APS), disorganized communication, suspiciousness, verbal 
memory, and a decline in social functioning were the best 
predictors of later transition to psychosis (the RAP model). 
The purpose of this article was to first test the prediction 
model of Cornblatt et  al with a new sample of individu-
als with APS from the PREDICT study. The RAP model 
was not the best fit for the PREDICT data. However, using 
other variables from PREDICT, it was demonstrated that 
unusual thought content, disorganized communication, 
baseline social functioning, verbal fluency, and memory, 
processing speed and age were predictors of later transi-
tion to psychosis in the PREDICT sample. Although the 
predictors were different in these 2 models, both supported 
that disorganized communication, poor social functioning, 
and verbal memory, were good candidates as predictors for 
later conversion to psychosis.
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Introduction
A major focus in the schizophrenia literature is the early 
identification of  those at risk for schizophrenia or other 
related psychotic disorders before the onset of  a psy-
chotic illness. The hope is that early intervention may 
slow down or even prevent the progression to a full blown 
psychotic illness. There already exist well-established 
criteria, the prodromal risk criteria,1,2 to determine this 
risk. These criteria identify 3 syndromal subgroups. 
The first is the attenuated positive symptom syndrome 
(APSS) which includes the emergence or worsening of 
nonpsychotic level disturbances in thought content, 
thought processes, or perceptual abnormalities in the 
past year. The second is the brief  intermittent psychotic 
symptom syndrome (BIPS) which requires the pres-
ence of  any one or more threshold positive psychotic 
symptoms (unusual thought content, suspiciousness, 
grandiosity, perceptual abnormalities, and disorganized 
communication) that are too brief  to meet diagnos-
tic criteria for psychosis. Finally, the third criterion is 
genetic risk and deterioration (GRD) which requires 
having a combination of  both functional decline and 
genetic risk (ie, either schizotypal personality disorder 
or a first-degree relative with a schizophrenia spectrum 
disorder).1 Individuals presenting with one of  these syn-
dromes are usually between 12 and 30  years old, and, 
since the criteria are clinically based, these individuals 
are considered to be at clinical high risk (CHR) for psy-
chosis. Approximately 20–35% of  these young people 
will develop fully blown psychotic symptoms over a 
2-year period, although the risk is often more imminent, 
as most of  the conversions occur during the first year 
after ascertainment with conversion rates decelerating 
after that first year.3,4
Several studies have examined, in addition to the 
CHR criteria, different combinations of  clinical and 
demographic variables to determine if  the 20–35% risk 
associated with CHR status can be improved upon.4–8 
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Unfortunately, there is often little consistency across 
these studies in terms of  both the domains chosen as 
well as the specific measures selected as potential pre-
dictors.9 Furthermore, these studies using combinations 
often end up with relatively high positive predictive val-
ues and specificity (eg, in the 50–70% range), but low 
sensitivity (eg, in the 10–30% range).4 More recent stud-
ies have considered adding biomarkers to their predic-
tion models10 which may result in important information 
about mechanisms. Regardless, even when only clinical 
and demographic variables are added, it is often that the 
best predictor of  transition to psychosis is the severity 
of  the attenuated psychotic symptoms.11 Thus, although 
the CHR criteria, in particular attenuated psychotic 
symptoms, have been validated as being sensitive to the 
risk of  transitioning to psychosis, at the present time 
their value in making predictions about individuals is 
limited. Finally, it should be noted that few studies have 
attempted direct replication of  each other’s risk algo-
rithms, which suggests heterogeneity among profiles of 
clinical and demographic risk indicators for those who 
make the transition to psychosis.
Cornblatt et  al9 have suggested that combining the 3 
subgroups of the CHR criteria, namely APSS, GRD, 
and BIPS, may have an impact on predictive validity in 
that the assumption that these 3 subgroups are similar 
in terms of risk and developmental trajectories is essen-
tially untested.12 In their recent study at the Recognition 
and Prevention (RAP) Program they excluded those who 
met BIPS and GRD criteria and selected their potential 
predictor variables primarily based on the vulnerability 
indicators they had described many years earlier.13 These 
included cognitive deficits, anxiety and depression, and 
social and role functioning difficulties. These domains 
had been selected as they were the domains most impli-
cated in schizophrenia and were potentially modifiable.13 
Results of this study were that in the final prediction 
model only symptoms (disorganized communication, 
suspiciousness), cognition (verbal memory deficits) and 
decline in social functioning were included. In addition 
to attenuated psychotic symptoms, which all participants 
need to have to meet CHR criteria, both cognition and 
social functioning have continually been demonstrated to 
be among the most common deficits observed in those at 
CHR.14–17
Enhancing the Prospective Prediction of  Psychosis 
(PREDICT)is a 2-year longitudinal study to deter-
mine predictors of  conversion in individuals at CHR of 
developing psychosis, conducted at the Universities of 
Toronto, North Carolina, and Yale. The main hypoth-
esis of  this study was that social functioning would be 
the best predictor of  later transition to psychosis with 
cognition also being an important predictor. We have 
previously published on substance use in this sample.18 
Approximately, 50% of  the sample used alcohol, 30% 
tobacco and 30% cannabis. Use of  other drugs was 
minimal. There were no differences between those who 
converted and those who did not for tobacco and can-
nabis; however, those who converted had slightly lower 
use of  alcohol.18
The first aim of  this article was to test the prediction 
model from the RAP sample presented by Cornblatt 
et  al.9 When the previous model did not fully repli-
cate, the second aim was to determine if  the RAP 
model could be improved upon with variables in the 
PREDICT sample. Potential predictors will include 
cognition and role and social functioning in addition 
to symptoms. Since this is exploratory we will consider 
several models.
Methods
Participants
The PREDICT sample consisted of  172 individuals who 
met the criteria of  prodromal syndromes (COPS) diag-
nostic criteria for 1 of  3 psychosis-risk syndromes: the 
APSS, the BIPS, or GRD.1 Participants were excluded 
if  they met criteria for any current or lifetime axis I psy-
chotic disorder, had a history or current use of  anti-
psychotic medications, had an IQ of  less than 70, or 
had past or current history of  a clinically significant 
central nervous system disorder. Since CHR syndromes 
other than APSS are infrequent, we restricted analysis 
to those diagnosed with APSS, either alone or in com-
bination with another CHR syndrome. One hundred 
sixty-eight CHR participants met APSS criteria, 4 met 
only GRD criteria without APSS and no participants 
met BIPS. Of the 168 meeting APSS criteria, 23 either 
dropped out after baseline or did not complete the base-
line assessment. Thus, for this article, the final sample 
consisted of  145 CHR individuals (82 males, 63 females) 
who met APSS criteria, and had at least one follow-up 
assessment. In this sample, 29 participants made the 
transition to psychosis.
Measures
The Structured Interview for Psychosis-risk Syndromes 
(SIPS) and the Scale of Psychosis-risk Symptoms (SOPS) 
were used to determine criteria for a prodromal syn-
drome, and to determine severity of attenuated positive 
symptoms.1
Social and Role functioning was assessed using the 
Social Functioning Scale (SFS), a self-report question-
naire developed for outpatients with schizophrenia and 
has been used for individuals at both the first episode and 
at CHR. The SFS has excellent psychometric properties.19 
The SFS has a total score and 7 subscores: withdrawal/
social engagement, interpersonal communication, inde-
pendence-performance, independence-competence, recre-
ation, prosocial, and employment/occupation. To better 
assess role functioning, we also used the instrumental role 
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functioning subscale of the Quality of Life Scale (QLS).20 
Using the last assessment carried forward we also cal-
culated a change over time score for the total SFS and 
for role.
Cognitive tests were chosen on the basis of their dem-
onstrated reliability, ability to discriminate patients with 
schizophrenia from healthy participants, lack of ceiling 
and floor effects in a CHR population, and appropriate-
ness for individuals as young as 14 years of age. Verbal 
fluency was assessed with Category Instances21 and the 
controlled word association tests (COWAT), verbal mem-
ory with the Rey Auditory Verbal Learning Test,22 ver-
bal working memory with the Letter-Number Sequencing 
Test,23 spatial working memory with the Computerized 
Test of Visuospatial Working Memory (CTVWM)24 
and the N-back task,25 attention with the Continuous 
Performance Test—Identical Pairs26 and Digit Span 
Distractibility, processing speed with Trails A,27 execu-
tive functioning with the Wisconsin Card Sorting Test, 
64-card computerized version (WCST),the Stroop Color-
Word Test28 and Trails B,27 motor function with Finger 
Oscillation Test27 and IQ with Wechsler Adult Intelligence 
Test/Wechsler Intelligence Scale for Children-III (Block 
Design, Arithmetic, Digit Symbol/Coding, Vocabulary, 
Information).
Procedures
Clinical raters were experienced research clinicians who 
demonstrated adequate reliability on the SIPS at routine 
reliability checks. Gold standard post-training agreement 
on the distinction between high risk and psychotic lev-
els of intensity was excellent (kappa  =  0.90). All cases 
were reviewed on weekly conference calls chaired by JA. 
Cognitive assessments were conducted by research assis-
tants, and pre- and post-doctoral neuropsychology fel-
lows trained by RK. RK held monthly conference calls to 
review any concerns or issues related to cognitive testing. 
Clinical assessments were conducted every 2 months for 
the first 6 months, and then every 6 months. Functioning 
and cognition were conducted at 6 monthly intervals. The 
study protocols and informed consents were reviewed 
and approved by the Institutional Review Boards of each 
site. All participants provided written, voluntary consent 
to participate.
Statistical Analysis
All analyses were conducted in SPSS version 21 and R 
version 3.3.1. Descriptive statistics were used to present 
means, standard deviations, and ranges of  all measures. 
To test the performance of  the RAP model in PREDICT, 
we applied the original regression formula provided 
by Cornblatt et al to our data to obtain the prognostic 
index (PI). We only have the L1 information (PI) from 
Cornblatt et  al. so we were only able to conduct very 
limited validation work related to discrimination but not 
calibration.
After observing that the RAP model did not repli-
cate well, we developed our model. We started with all 
20 candidate variables for our full model (demographic 
variables, antidepressant medications at baseline, symp-
toms from the SOPS, cognitive variables, and social and 
role functioning), and then the least absolute shrinkage 
and selection operator (LASSO) method for variable 
selection in the cox regression model was used. This 
is a new method for variable selection and shrinkage 
in cox regression models which reduces the estimation 
variance while providing an interpretable final model.29 
A reasonable range of  the tuning parameter λ (lambda) 
values appropriate for the data set was calculated by 
using GLMNET package in R.30 The cross-validated 
performance of  the model for each value of  λ was esti-
mated to find the optimal value for the λ that gives mini-
mum mean cross-validation error, and the optimal λ was 
chosen for fitting our final model in the total sample. 
The cross-validated predictive performance (Harrel’s 
c-index) of  our full model and the final model was esti-
mated by using MLR package in R.31 The prognostic 
index (PI), Harrel’s c-index of  concordance, Kaplan–
Meier curves for 3 risk groups and baseline cumulative 
hazard function of  the final model was provided for 
external validation.
Results
The sample consisted of 82 males and 63 females. Mean 
age was 19.84 years (SD = 4.69, range 12–31). The major-
ity were white (75.9%), 68.6% had completed high school 
and 32.1% had some form of degree or professional train-
ing either from a University or community college. Mean 
scores and ranges for all measures used are presented in 
Table 1.
In terms of DSM-IV diagnoses, 38 (26.3%) had a cur-
rent mood disorder and 69 (47.9%) reported a previous 
mood disorder. Sixty-three (43.4) had a current anxiety 
disorder and 71 (48.9%) reported a previous anxiety dis-
order. Five participants met criteria for obsessive com-
pulsive disorder. Sixty participants (41.4%) were taking 
psychotropic medication at baseline. Forty-eight (33%) 
were taking an antidepressant. Differences between those 
who converted and those who did not are presented in 
Table 2. The groups only differed in social functioning, 
verbal memory, and verbal fluency with the converters 
always performing more poorly.
In the PREDICT sample, 11.2% of  the data overall 
were missing. Missing data were handled using expec-
tation-maximization estimates. Thus, there were no 
differences in the sample used to test the RAP model 
and the PREDICT model (145 observations in each 
sample).
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Table 2. Differences Between Those Who Converted and Those Who Did Not
Variable
CHR Nonconverters  
(n = 116) Mean (SD)
CHR Converters  
(n = 29) Mean (SD) t Value
Age 19.89 (4.72) 19.68 (4.62) −0.22
P1 unusual thought content 3.20 (1.09) 3.45 (1.24) 1.07
P2 suspiciousness 2.59 (1.26) 2.83 (1.47) 0.86
P3 grandiosity 1.26 (1.31) 0.90 (1.11) −1.37
P4 perceptual abnormalities 2.59 (1.44) 2.41 (1.45) −0.60
P5 disorganized communication 1.48 (1.11) 1.90 (1.21) 1.76
SOPS total positive symptoms 11.13 (3.20) 11.48 (2.96) 0.54
QLS—role functioning 13.01 (4.49) 11.04 (6.07) −1.64
Total SFS score 129.08 (17.17) 113.84 (23.93) −3.23**
Change over time in role 1.75 (4.50) 2.00 (3.60) 0.27
Change over time in SFS 7.73 (16.60) 16.42 (13.12) 2.62*
IQ score 111.15 (16.54) 105.08 (19.87) −1.69
Verbal memory z score 0.09 (0.83) −0.36 (0.84) −2.59*
Spatial working memory score 0.05 (0.89) −0.20 (0.92) −1.35
Executive functioning z score −0.03 (0.44) 0.13 (0.71) 1.48
Distractibility z score 0.05 (1.04) −0.20 (0.83) −1.20
Verbal fluency z score 0.10 (0.85) −0.39 (0.93) −2.69**
Processing speed z score −0.52 (0.99) 0.21 (1.03) 1.27
Motor function z score 0.06 (0.87) −0.22 (1.16) −1.39
Diagnoses N (%) N (%) Chi-square
Lifetime depression 54 (46.5) 15 (51.7) 0.21
Lifetime anxiety 54 (47) 17 (58.6) 1.26
Current depression 27 (23.5) 11 (37.9) 2.49
Current anxiety 49 (42.6) 14 (48.3) 0.30
Medications
Any psychotropic medication 48 (41.4) 12 (41.4) 0.00
Anti-depressant 38 (32.8) 10 (34.5) 0.03
*P < .05. **P < .01.
Table 1. Means, Standard Deviations, and Ranges of All Measures
Variable Mean (SD) Range
Symptoms
 P1 unusual thought content 3.25 (1.12) 0–5
 P2 suspiciousness 2.64 (1.30) 0–5
 P3 grandiosity 1.19 (1.27) 0–5
 P4 perceptual abnormalities 2.56 (1.44) 0–5
 P5 disorganized communication 1.57 (1.14) 0–5
Functioning
 Total SFS score 126.03 (19.60) 45–172
 QLS—role functioning 12.61 (4.89) 0–18
Cognition
 IQ 109.93 (17.36) 72–151
 Verbal fluency—category instances 46.97 (11.73) 19–84
 Verbal fluency—controlled word association 37.89 (12.07) 14–77
 Total trials of Rey auditory verbal learning test 57.75 (10.01) 1–72
 Verbal working memory—letter number sequencing 15.67 (3.55) 3–24
 Visual spatial memory—n-back task 80.90 (27.99) 17–126
 Attention—continuous performance test 7.72 (1.93) 2.7–12.18
 Attention—digit span distractibility 30.58 (5.44) 9–35
 Processing speed—Trails A 27.51 (10.48) 10–79
 Executive functioning—Trails B 63.55 (28.15) 28–224
 Executive functioning—stroop color/number 46.32 (11.44) 13–77
 Executive functioning—perseverative errors (WCST) 7.42 (4.31) 3–29
 Motor function—finger oscillation 84.41 (21.10) 17–126
*P < .05. **P < .01.
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Testing the RAP Model
For the external validation of the RAP model in 
PREDICT, we addressed the discrimination by conduct-
ing regression on the PI in our data and checking the mea-
sures of discrimination. The slope on the PI was 0.073 
which is less than 1. For the measures of discrimination, 
Harrel’s c-index of concordance was 0.55 which means 
the predictive performance of the RAP model was poor.
The PREDICT Model
The final model, consisted of 7 variables: baseline social 
functioning, verbal fluency, unusual thought content, 
verbal memory, disorganized communication, processing 
speed, and age (Table 3).
The full model with all 20 candidate variables has a 
cross-validated Harrel’s c-index of concordance of 0.71. 
Our final model has a cross-validated Harrel’s c-index 
of concordance of 0.73. The formula to calculate the PI 
for our final model was: 0.13  × (unusual thought con-
tent) + 0.096 × (disorganized communication) − 0.21 × 
(verbal fluency z score) − 0.11 × (verbal memory z score) 
+ 0.071  × (processing speed z score) −0.49  × (baseline 
social functioning z score) + 0.02 × age.
Kaplan–Meier curves for the 3 risk groups are pre-
sented in figure 1. To give a reasonable spread of risk, we 
chose 3 prognostic groups which are good, fairly good 
and poor. The required cut-points are the 27th and 73th 
centiles of the continuous variable, the PI in our data-
set. The absolute values are 0.49 and 1.19, respectively. 
A look-up table for baseline cumulative hazard function 
is presented as Supplementary Table 1.
Discussion
The aim of this article was to report on testing the RAP 
model of prediction of conversion to psychosis in a dif-
ferent study, PREDICT, another longitudinal study of 
conversion to psychosis. Secondly, we reported on a pre-
diction model within the PREDICT sample with poten-
tial predictors being social and role functioning and 
cognition in addition to attenuated psychotic symptoms. 
The sample for both models was limited to only partici-
pants meeting APS criteria.
The RAP model was not the best fit for our PREDICT 
data. The slope on the PI was 0.07 suggesting poor dis-
crimination. Harrel’s c-index of concordance was 0.55 
which means the predictive performance of the RAP 
model in our data was poor.
The final PREDICT model consisted of 7 variables which 
ranked according to their standardized regression coeffi-
cients included baseline social functioning, verbal fluency, 
unusual thought content, verbal memory, disorganized 
communication, processing speed, and age. Individuals 
with poorer baseline social functioning, poorer verbal flu-
ency, increased severity ratings on unusual thought con-
tent, poorer verbal memory, increased severity ratings on 
disorganized communication, poorer processing speed, 
and older age have higher rates of conversion to psychosis.
One of the goals of testing the different models was 
to determine their consistency, and indeed the RAP 
and PREDICT models are similar. Suspiciousness and 
unusual thought content are 2 of the most common 
attenuated psychotic symptoms,32 suspiciousness was a 
predictor in RAP and unusual thought content was a pre-
dictor in PREDICT. Other prediction models such as the 
North American Prodromal Study (NAPLS1) reported 
that both unusual thought content and suspiciousness 
were significant predictors in their model,4 and later in 
NAPLS 233 both unusual thought and suspiciousness 
were highly relevant in prediction. Secondly, both the 
RAP and PREDICT models report on social functioning 
as a significant predictor, the difference being that in RAP 
it is decline over time whereas in PREDICT it is baseline 
social functioning. Again, both have been reported in 
other studies with social functioning over the past year 
being a predictor in the EPOS model7 and baseline social 
impairment being a predictor in NAPLS 1.4
Table 3. LASSO cox regression model
Variable
Unstandardized 
Coefficient
Standardized  
Coefficient
Baseline social functioning z score −0.49 −0.53
Verbal fluency z score −0.21 −0.25
Unusual thought content 0.13 0.15
Verbal memory z score −0.11 −0.13
Disorganized communication 0.096 0.12
Processing speed z score 0.071 0.094
Age 0.02 0.03
Fig. 1. Kaplan–Meier survival estimates in 3 risk groups. Kaplan–
Meier curves for 3 risk groups are presented. To give a reasonable 
spread of risk, we chose 3 prognostic groups which are good, fairly 
good, and poor. The required cut-points are the 27th and 73th 
centiles of the continuous variable, the PI in our dataset. Absolute 
values are 0.49 and 1.19.
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RAP reported verbal memory as a significant predic-
tor whereas PREDICT reported verbal fluency, and pro-
cessing speed in addition to verbal memory. Two other 
projects examining cognition as a predictor in addition to 
other factors reported processing speed as significant.6,8 In 
schizophrenia, cognitive deficits are common with verbal 
memory and verbal fluency often being the most severe, 
as well as speed of processing. In contrast to the results 
of both the PREDICT and RAP studies, Ziermans et al34 
reported that full scale IQ was the only cognitive marker 
that added to the prediction accuracy. However, this was 
a much smaller (N = 43) and younger (12–18 years) sam-
ple which was comprised of at risk youth and not limited 
to only those meeting APSS.
There are several limitations of this study. First, there 
were differences between RAP and PREDICT. Entry 
criteria for PREDICT was that the attenuated psychotic 
symptoms had to have begun or worsened in the past 
year; whereas in the RAP sample this restriction was 
not applied. The studies differed in their measures of 
functioning. RAP used measures that were specifically 
designed for youth at high risk of psychosis35 whereas 
PREDICT used measures of social and role function-
ing that were typically used in psychotic populations. 
Furthermore, in PREDICT it was difficult to examine 
decline in social functioning due to the extent of missing 
follow-up data with the implication that our imputation 
may be less valid. However, PREDICT did have more 
missing social functioning follow-up data in the convert-
ers (68.9%) compared to the nonconverters (30.2%). This 
may have resulted from differences in the mean time from 
baseline assessment to conversion to psychosis, which was 
1.78 years in RAP compared to 0.89 years in PREDICT.
Secondly, there were differences in the assessment 
of cognition. RAP did not assess verbal fluency. With 
respect to verbal memory, RAP created a verbal mem-
ory score from the total and delayed recall score of the 
California Verbal Learning Test, plus the immediate 
and delayed logical memory from the Wechsler Memory 
Scale, Revised. PREDICT created a verbal memory score 
from the Rey total score, and the letter-number test of 
auditory working memory.
In a recent article, Studerus et  al36 reviewed 6 stud-
ies that included neurocognitive measures in prediction 
models that contained other variables. These authors 
concluded that although the majority of these prediction 
studies offered support to neurocognitive measures mak-
ing a unique contribution to the prediction of psychosis, 
such measures generally seemed to be weaker predictors 
than clinical measures. In fact, Studerus et  al36 suggest 
that when clinical measures are considered the strength 
of the association of neurocognitive measures with tran-
sition is weakened.
Limitations of prediction studies such as reported here 
often do not address the fact that the predictive marker 
may at times be dependent on its developmental trajectory. 
For social functioning, these studies did address change 
over time. Future models may want to consider using 
similar “developmental” measures for cognition. Results 
presented in this article support the position of Cornblatt 
et al9 that these prediction models tend to capitalize on 
associations within a given sample and that locally devel-
oped models should only be expected to work on samples 
that were recruited in the same way and possibly the same 
or similar locations. Furthermore, it would be important 
to use the same measures across studies, since one pos-
sible reason for the lack of convergent results is the use 
of different instruments. As has been done for cogni-
tion through the National Institute of Mental Health, 
it may be timely to begin to develop consensus batteries 
for assessing CHR individuals in order to achieve better 
predictive value. It may take several samples and several 
studies to begin to approach what the “true predictors” 
might be.
In summary, in this article we first demonstrated that 
the RAP model was not the best fit for the PREDICT 
data and then examined PREDICT to determine the 
optimal predictors in the PREDICT sample with an eye 
to the later possible meta-analysis of consistency of opti-
mal predictors across samples. What does seem to be con-
sistent at this stage is that severe levels of unusual thought 
and/or suspiciousness, poor social functioning and cogni-
tive functioning in particular verbal memory and/or ver-
bal fluency are highly potential candidate predictors.
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